PMGC (NASDAQ:ELAB) Shares Scheduled to Reverse Split on Tuesday, January 6th

PMGC Holdings Inc. (NASDAQ:ELAB) shares are going to reverse split before the market opens on Tuesday, January 6th. The 1-4 reverse split was announced on Friday, January 2nd. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, January 5th.

PMGC Stock Down 4.1%

NASDAQ ELAB traded down $0.06 on Friday, hitting $1.42. 478,161 shares of the stock were exchanged, compared to its average volume of 999,081. PMGC has a fifty-two week low of $1.25 and a fifty-two week high of $99.72. The company has a 50-day moving average price of $4.34 and a 200-day moving average price of $5.86. The company has a market cap of $965,600.00, a PE ratio of -0.08 and a beta of 0.70.

PMGC (NASDAQ:ELAB) last announced its quarterly earnings data on Friday, November 14th. The company reported ($4.95) EPS for the quarter. The business had revenue of $0.29 million for the quarter.

Wall Street Analysts Forecast Growth

ELAB has been the topic of a number of analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of PMGC in a research note on Monday. Wall Street Zen upgraded PMGC to a “sell” rating in a report on Saturday, October 25th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, PMGC presently has an average rating of “Sell”.

About PMGC

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.